Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-21-044606
Filing Date
2021-07-01
Accepted
2021-07-01 19:45:43
Documents
1
Period of Report
2021-06-29

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 12530
  Complete submission text file 0001209191-21-044606.txt   14766
Mailing Address 350 106TH AVENUE NE, 1ST FLOOR BELLEVUE WA 98004
Business Address 350 106TH AVENUE NE, 1ST FLOOR BELLEVUE WA 98004 (425) 709-0772
Qiming U.S. Healthcare Fund II, L.P. (Reporting) CIK: 0001765710 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-40523 | Film No.: 211067670

Mailing Address 888 SEVENTH AVE 12TH FLOOR NEW YORK NY 10106
Business Address 888 SEVENTH AVE 12TH FLOOR NEW YORK NY 10106 212-651-6380
Elevation Oncology, Inc. (Issuer) CIK: 0001783032 (see all company filings)

IRS No.: 841771427 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 11100 NE 8TH ST, SUITE 200 BELLEVUE WA 98004
Business Address 11100 NE 8TH ST, SUITE 200 BELLEVUE WA 98004 425-709-0772
Qiming U.S. Healthcare GP II, LLC (Reporting) CIK: 0001868862 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-40523 | Film No.: 211067669